My Quote Request
No products added yet
6505-01-240-5767
20 Products
TAMBOCOR TABLETS
FELCAINIDE ACETATE TABLETS,USP
NSN, MFG P/N
6505012405767
NSN
6505-01-240-5767
TAMBOCOR TABLETS
FELCAINIDE ACETATE TABLETS,USP
NSN, MFG P/N
6505012405767
NSN
6505-01-240-5767
MFG
3M COMPANY HEALTH CARE/MFG
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS FLECAINIDE ACETATE ACTIVE INGREDIENT
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLECAINIDE ACETATE TABLETS USP 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SCORED TABLETS
Related Searches:
NDC00228-2143-96
CARBAMAZEPINE TABLETS,USP
NSN, MFG P/N
6505012406226
NSN
6505-01-240-6226
NDC00228-2143-96
CARBAMAZEPINE TABLETS,USP
NSN, MFG P/N
6505012406226
NSN
6505-01-240-6226
MFG
ACTAVIS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS CARBAMAZEPINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: PUREPAC PHARMACEUTICAL CO.
Related Searches:
NDC50474-0100-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012406891
NSN
6505-01-240-6891
NDC50474-0100-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012406891
NSN
6505-01-240-6891
MFG
UCB PHARMA INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.40 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 20.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0097 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.139 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 100MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: THEO-24 BY SEARLE LABORATORIES
Related Searches:
THE0-24
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012406891
NSN
6505-01-240-6891
THE0-24
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012406891
NSN
6505-01-240-6891
MFG
SEARLE G D AND CO
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.40 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 20.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0097 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.139 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 100MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: THEO-24 BY SEARLE LABORATORIES
Related Searches:
NDC50474-0200-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012406892
NSN
6505-01-240-6892
NDC50474-0200-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012406892
NSN
6505-01-240-6892
MFG
UCB PHARMA INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.40 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 26.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0097 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.18 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: THEO-24 BY SEARLE LABORATORIES
Related Searches:
NDC50474-2842-06
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012406892
NSN
6505-01-240-6892
NDC50474-2842-06
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012406892
NSN
6505-01-240-6892
MFG
SEARLE G D AND CO
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.40 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 26.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0097 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.18 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: THEO-24 BY SEARLE LABORATORIES
Related Searches:
THEO-24
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012406892
NSN
6505-01-240-6892
THEO-24
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012406892
NSN
6505-01-240-6892
MFG
SEARLE G D AND CO
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.40 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 26.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0097 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.18 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: THEO-24 BY SEARLE LABORATORIES
Related Searches:
NDC50474-0300-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012406893
NSN
6505-01-240-6893
NDC50474-0300-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012406893
NSN
6505-01-240-6893
MFG
UCB PHARMA INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.40 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 96
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 24.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0146 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.25 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
Related Searches:
THEO-24
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012406893
NSN
6505-01-240-6893
THEO-24
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012406893
NSN
6505-01-240-6893
MFG
SEARLE G D AND CO
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.40 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 96
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 24.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0146 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.25 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
Related Searches:
NDC00536-3435-01
CARISOPRODOL TABLETS
NSN, MFG P/N
6505012407597
NSN
6505-01-240-7597
NDC00536-3435-01
CARISOPRODOL TABLETS
NSN, MFG P/N
6505012407597
NSN
6505-01-240-7597
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 350.000 MILLIGRAMS CARISOPRODOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: UNCOATED
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
NDC00054-4016-31
ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505012407598
NSN
6505-01-240-7598
NDC00054-4016-31
ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505012407598
NSN
6505-01-240-7598
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: OTC DRUG--NOT LISTED
Related Searches:
NDC00814-0284-06
ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505012407598
NSN
6505-01-240-7598
NDC00814-0284-06
ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505012407598
NSN
6505-01-240-7598
MFG
I D E INTERSTATE INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: OTC DRUG--NOT LISTED
Related Searches:
NDC00182-1132-89
CYPROHEPTADINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012408699
NSN
6505-01-240-8699
NDC00182-1132-89
CYPROHEPTADINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012408699
NSN
6505-01-240-8699
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS CYPROHEPTADINE HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CYPROHEPTADINE HYDROCHLORIDE TABLETS USP 4MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC51079-0159-20
CYPROHEPTADINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012408699
NSN
6505-01-240-8699
NDC51079-0159-20
CYPROHEPTADINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012408699
NSN
6505-01-240-8699
MFG
UDL LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS CYPROHEPTADINE HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CYPROHEPTADINE HYDROCHLORIDE TABLETS USP 4MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC57480-0428-01
CYPROHEPTADINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012408699
NSN
6505-01-240-8699
NDC57480-0428-01
CYPROHEPTADINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012408699
NSN
6505-01-240-8699
MFG
MEDIREX INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS CYPROHEPTADINE HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CYPROHEPTADINE HYDROCHLORIDE TABLETS USP 4MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00409-1902-01
PROCAINAMIDE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012408703
NSN
6505-01-240-8703
NDC00409-1902-01
PROCAINAMIDE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505012408703
NSN
6505-01-240-8703
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS PROCAINAMIDE HYDROCHLORIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROCAINAMIDE HYDROCHLORIDE INJECTION USP 100MG/ML 10ML VIAL 25S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00008-2529-03
HEPARIN LOCK FLUSH KIT
NSN, MFG P/N
6505012412226
NSN
6505-01-241-2226
NDC00008-2529-03
HEPARIN LOCK FLUSH KIT
NSN, MFG P/N
6505012412226
NSN
6505-01-241-2226
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
SPECIAL FEATURES: UNIT OF USE KITS; COMPONENTS QUANTITY 3; TOTAL PRIMARY CONTAINER QUANTITLOCK FLUSH SOLUTION,USP,100 UNITS PER ML 1; 1 ML SIZE (25GX5/8 INCH) TUBEX BACTERIOSTATIC SODIUM CHLORIDE INJECTION,USP,2
Related Searches:
TUBEX HEPARIN FLUSH KITS
HEPARIN LOCK FLUSH KIT
NSN, MFG P/N
6505012412226
NSN
6505-01-241-2226
TUBEX HEPARIN FLUSH KITS
HEPARIN LOCK FLUSH KIT
NSN, MFG P/N
6505012412226
NSN
6505-01-241-2226
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
SPECIAL FEATURES: UNIT OF USE KITS; COMPONENTS QUANTITY 3; TOTAL PRIMARY CONTAINER QUANTITLOCK FLUSH SOLUTION,USP,100 UNITS PER ML 1; 1 ML SIZE (25GX5/8 INCH) TUBEX BACTERIOSTATIC SODIUM CHLORIDE INJECTION,USP,2
Related Searches:
NDC00009-0010-04
TRIAZOLAM TABLETS,USP
NSN, MFG P/N
6505012413591
NSN
6505-01-241-3591
NDC00009-0010-04
TRIAZOLAM TABLETS,USP
NSN, MFG P/N
6505012413591
NSN
6505-01-241-3591
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.125 MILLIGRAMS TRIAZOLAM ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAZOLAM TABLETS USP I.S. 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: REVERSE NUMBER PACK
THERAPEUTIC EQUIVALENT: HALCION BY UPJOHN CO.
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
73513
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505012415747
NSN
6505-01-241-5747
73513
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505012415747
NSN
6505-01-241-5747
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS MIDAZOLAM EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MIDAZOLAM HYDROCHLORIDE INJECTION 5MG/ML 2ML VIAL 10S PG
III PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 10
